Related Experiment Videos
[Conservative therapy of malignant pleural effusion]
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|January 1, 1992
Summary
Nonsurgical treatment for malignant pleural effusion focuses on palliative care with minimal risks. Talc pleurodesis is superior to tetracycline for reducing recurrence, with a median survival of 9 months.
Area of Science:
- Pulmonology
- Oncology
- Thoracic Surgery
Context:
- Malignant pleural effusion (MPE) management requires palliative strategies with minimal patient risk.
- Accurate histologic diagnosis is crucial before initiating treatment for MPE.
Purpose:
- To review nonsurgical treatment options for malignant pleural effusion.
- To evaluate the efficacy and safety of different palliative procedures for MPE.
Summary:
- Thoracoscopy provides a reliable histologic diagnosis for MPE (>90% accuracy).
- Nonsurgical treatments include systemic chemotherapy and local procedures like pleurodesis.
- Talc pleurodesis demonstrates superior efficacy over tetracycline in preventing MPE recurrence.
- Median patient survival was 9 months.
Impact:
- Highlights talc pleurodesis as a highly effective palliative treatment for malignant pleural effusion.
- Emphasizes the importance of accurate diagnosis and risk-benefit assessment in MPE management.
- Provides evidence-based recommendations for improving patient outcomes in malignant pleural effusion.